Bryn Mawr Capital Management LLC Buys 9,751 Shares of Colgate-Palmolive (NYSE:CL)

Bryn Mawr Capital Management LLC increased its stake in shares of Colgate-Palmolive (NYSE:CLFree Report) by 91.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,433 shares of the company’s stock after purchasing an additional 9,751 shares during the quarter. Bryn Mawr Capital Management LLC’s holdings in Colgate-Palmolive were worth $1,858,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of CL. Centricity Wealth Management LLC acquired a new position in Colgate-Palmolive in the fourth quarter valued at approximately $27,000. Union Bancaire Privee UBP SA acquired a new position in Colgate-Palmolive in the fourth quarter valued at approximately $32,000. Hager Investment Management Services LLC acquired a new position in Colgate-Palmolive in the fourth quarter valued at approximately $36,000. Reston Wealth Management LLC acquired a new position in Colgate-Palmolive in the third quarter valued at approximately $42,000. Finally, Roxbury Financial LLC acquired a new position in Colgate-Palmolive in the fourth quarter valued at approximately $43,000. 80.41% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts recently weighed in on CL shares. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. TD Cowen cut their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. Piper Sandler cut their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. Morgan Stanley cut their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. Finally, Barclays cut their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, Colgate-Palmolive has a consensus rating of “Hold” and an average price target of $101.16.

View Our Latest Analysis on CL

Colgate-Palmolive Stock Down 2.3 %

Colgate-Palmolive stock opened at $90.17 on Thursday. The company has a market cap of $73.18 billion, a P/E ratio of 25.62, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a fifty day simple moving average of $88.81 and a 200 day simple moving average of $95.62. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the company earned $0.87 earnings per share. Research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.22%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 56.82%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.